Atomwise
San Francisco, US · Founded 2015 · Delaware corporation · 12 known investors
Atomwise uses artificial intelligence and machine learning to discover novel small-molecule drugs, with a current focus on developing treatments for immune and inflammatory diseases.
AI & Machine LearningBiotechDeep Tech
Founders & leadership
Atomwise was founded in 2015 by Izhar Wallach and Abraham Heifets.
IW
Izhar WallachCo-founder
AH
Abraham HeifetsCo-founder
YZ
Yan ZhaoExecutive
SW
Stephen WorlandExecutive
Board
RM
AS
GT
Gavin TeoBoard director
KS
LM
Linda MaxwellBoard director
MV
Mike VarneyBoard director
Investors · 12
Aurum Venture PartnersPleasanton
.jpeg){kind=logo}
B Capital GroupManhattan Beach · $10M – $50M
Cerity Partners VenturesNew York
Creative Destruction Lab (CDL)Toronto · $50K – $250K
Draper AssociatesSan Mateo · $500K – $5M
Threshold VenturesPalo Alto · $500K – $20M
Unruly CapitalLondon
Vickers Venture PartnersSingapore
B4 Capitalreported$10M – $50Mvia Raj Ganguly · board
DCVC (Data Collective)reportedPalo Alto · $5M – $25M
Dolby Family VenturesreportedSan Francisco
OS FundreportedPark Ridge · $1M – $2M
Funding
SEC filings, press & company announcements$238.6M disclosed across 4 of 6 rounds · 2018–2026
▶$19.8MraisedMar 2026 · 5 investors · BiotechnologyRule 506(b)
▶$19.8MraisedMar 2026 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stephen WorlandExecutive Officer, Director
- Adam SeabrookDirector
- Izhar WallachDirector
- Yan ZhaoExecutive Officer
- Mike VarneyDirector
- Robert MittendorffDirector
- Linda MaxwellDirector
- Offering amount
- $35M
- Amount sold
- $19.8M
- First sale
- Mar 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$44.3MraisedMar 2025 · 19 investors · BiotechnologyRule 506(b)
▶$44.3MraisedMar 2025 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert MittendorffDirector
- Adam SeabrookDirector
- Linda MaxwellDirector
- Mike VarneyDirector
- Izhar WallachExecutive Officer, Director
- Yan ZhaoExecutive Officer
- Stephen WorlandExecutive Officer, Director
- Offering amount
- $50M
- Amount sold
- $44.3M
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$123MraisedAug 2020 · 25 investors · BiotechnologyRule 506(b)
▶$123MraisedAug 2020 · 25 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Izhar WallachExecutive Officer, Director
- Raj GangulyDirector
- Abraham HeifetsExecutive Officer, Director
- Matt OckoDirector
- Han LimExecutive Officer
- Offering amount
- $127M
- Amount sold
- $123M
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$51.5MraisedJul 2018 · 31 investors · BiotechnologyRule 506(b)
▶$51.5MraisedJul 2018 · 31 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gavin TeoDirector
- Matt OckoDirector
- Kiersten SteadDirector
- Izhar WallachExecutive Officer, Director, Promoter
- Abraham HeifetsExecutive Officer, Director, Promoter
- Offering amount
- $51.5M
- Amount sold
- $51.5M
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 6
by search overlap
Atomic AI11 shared keywordsAtomic.ai combines machine learning and RNA biology to discover and develop RNA-based drugs. The company applies computational approaches to advance RNA therapeutics.
Atom Computing5 shared keywordsAtom Computing develops large-scale quantum computers using optically-trapped neutral atoms for on-premises deployment. The systems are designed to serve companies and researchers working on computationally intensive applications.
Atoms5 shared keywordsBuilds automated kitchen systems using robotics to produce consistent, affordable meals at scale.
Atomic Labs5 shared keywordsAtomic is a venture studio that co-founds companies, providing ideas, capital, talent, and operational playbooks alongside co-founders to build startups.
Edgewise Therapeutics4 shared keywordsEdgewise Therapeutics develops novel therapeutics for serious cardiovascular muscle diseases, including hypertrophic cardiomyopathy (HCM) and heart failure. The company focuses on drug development targeting cardiac muscle for patients with life-limiting cardiovascular conditions.
Atomic Canyon3 shared keywordsAtomic Canyon builds AI-powered search and generative AI tools, including its Neutron product, that process nuclear documentation and terminology to support document retrieval, compliance, and plant operations for the nuclear energy industry. It works with the U.S. Nuclear Regulatory Commission's database and has partnered with PG&E's Diablo Canyon Power Plant for on-site generative AI deployment.</parameter>
<parameter name="founders">[]
Companies competing with Atomwise for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Atomwise do?
- Atomwise uses artificial intelligence and machine learning to discover novel small-molecule drugs, with a current focus on developing treatments for immune and inflammatory diseases.
- Who founded Atomwise?
- Atomwise was founded by Izhar Wallach, Abraham Heifets in 2015.
- Who are Atomwise's investors?
- Atomwise's investors include Aurum Venture Partners, B Capital Group, Cerity Partners Ventures, Creative Destruction Lab (CDL), Draper Associates, Threshold Ventures, Unruly Capital, Vickers Venture Partners and 4 more.
- How much funding has Atomwise raised?
- Atomwise has disclosed $238.6M raised across 4 of its 6 known rounds.
- Where is Atomwise headquartered?
- Atomwise is headquartered in San Francisco, US.